PUCKETT DAN 4
4 · Shockwave Medical, Inc. · Filed Feb 6, 2024
Insider Transaction Report
Form 4
PUCKETT DAN
CFO & Secretary
Transactions
- Sale
Common Stock
2024-02-05$230.99/sh−1,703$393,376→ 22,231 total - Tax Payment
Common Stock
2024-02-05$226.29/sh−1,077$243,714→ 24,447 total - Sale
Common Stock
2024-02-05$231.84/sh−1,226$284,236→ 21,005 total - Tax Payment
Common Stock
2024-02-05$226.29/sh−2,208$499,648→ 25,524 total - Tax Payment
Common Stock
2024-02-05$226.32/sh−213$48,206→ 24,234 total - Sale
Common Stock
2024-02-05$229.27/sh−300$68,781→ 23,934 total
Footnotes (4)
- [F1]All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 09/08/2023.
- [F2]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $229.12 to $229.34. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F3]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $230.67 to $231.63. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F4]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $231.70 to $232.07. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.